Quadruple therapy with standard triple therapy for Helicobacter pylori eradication efficacy.doc

Quadruple therapy with standard triple therapy for Helicobacter pylori eradication efficacy.doc

  1. 1、本文档共10页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Quadruple therapy with standard triple therapy for Helicobacter pylori eradication efficacy

 PAGE \* MERGEFORMAT 10 Quadruple therapy with standard triple therapy for Helicobacter pylori eradication efficacy Abstract Objective To observe the colloidal bismuth pectin, pantoprazole, amoxicillin and clarithromycin, quadruple therapy with the composition of pantoprazole, amoxicillin and clarithromycin composition of standard triple therapy, eradication of H. Lo bacilli (HP) of the efficacy and safety. Methods 98 patients with peptic ulcer or chronic gastritis and HP-positive adult patients were randomly divided into 2 groups. The treatment group of 50 patients: Bismuth Pectin 100mg orally 3 times a day, pantoprazole 40mg 2 times a day orally, 3 times a day amoxicillin 500mg oral clarithromycin 500mg 2 times a day orally. Control group, 48 cases: 2 pantoprazole 40mg daily oral dose of amoxicillin 500mg orally 3 times a day, clarithromycin 500mg 2 times a day orally, the withdrawal of 4 weeks HP. HP eradication rate of the treatment group 92% in the control group the eradication rate of 79.2%, the two groups was statistically significant (P lt;0.05). The incidence of adverse reactions was 16% and 14.6%, the incidence of adverse reactions compared the two groups was not significant (Pgt; 0.05). Conclusion quadruple therapy compared with triple therapy for eradication of HP better. Keywords: quadruple therapy with standard triple therapy for Helicobacter pylori 1 INTRODUCTION Helicobacter pylori colonization in gastric mucosa is a surface micro-aerobic. 1982 Australian scholar MasShal and Warren first isolated and cultured from Helicobacter pylori on gastric mucosa, and proved it with gastroduodenal diseases, especially chronic gastritis and peptic ulcer pathogenesis. After 20 years of worldwide research results show a large number of Helicobacter pylori in chronic gastritis and peptic ulcer disease, but also the bacteria and the incidence of gastric cancer and gastric MALT lymphoma is also closely related to [1] . The HP infection and

文档评论(0)

hhuiws1482 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:5024214302000003

1亿VIP精品文档

相关文档